1. Biomolecular imaging of colorectal tumor lesions using a FITC-labeled scFv-Cκ fragment antibody.
- Author
-
Kim HI, Kim J, Kim H, Lee H, Yoon YS, Hwang SW, Park SH, Yang DH, Ye BD, Byeon JS, Yang SK, Kim SY, and Myung SJ
- Subjects
- Adenocarcinoma pathology, Animals, Biomarkers, Tumor immunology, Calcium-Binding Proteins immunology, Colorectal Neoplasms pathology, Female, Fluorescein-5-isothiocyanate, Fluorescent Antibody Technique methods, HCT116 Cells, HEK293 Cells, Humans, Male, Mice, Mice, Inbred BALB C, Middle Aged, Adenocarcinoma diagnostic imaging, Colonoscopy methods, Colorectal Neoplasms diagnostic imaging, Optical Imaging methods, Single-Chain Antibodies immunology
- Abstract
For the sensitive diagnosis of colorectal cancer lesions, advanced molecular imaging techniques using cancer-specific targets have emerged. However, issues regarding the clearance of unbound probes and immunogenicity remain unresolved. To overcome these limitations, we developed a small-sized scFv antibody fragment conjugated with FITC for the real-time detection of colorectal cancer by in vivo molecular endoscopy imaging. A small-sized scFv fragment can target colon cancer secreted protein-2 (CCSP-2), highly expressed in colorectal adenocarcinoma tissues; moreover, its full-length IgG probe has been used for molecular imaging previously. To assess the efficacy of anti-CCSP-2 scFv-FITC, surgical specimens were obtained from 21 patients with colorectal cancer for ex vivo molecular fluorescence analysis, histology, and immunohistochemistry. Orthotopic mice were administered with anti-CCSP-2 scFv-FITC topically and intravenously, and distinct tumor lesions were observed by real-time fluorescence colonoscopy. The fluorescence imaging of human colon cancer specimens allowed the differentiation of malignant tissues from non-malignant tissues (p < 0.05), and the CCSP-2 expression level was found to be correlated with the fluorescence intensity. Here, we demonstrated the feasibility and safety of anti-CCSP-2 scFv-FITC for molecular imaging as well as its potential in real-time fluorescence colonoscopy for the differential diagnosis of tumor lesions., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF